Paper

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Published Jul 1, 2013 · F. Martinez, R. Roberts, G. Raghu

The Lancet. Respiratory medicine

363

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Highly Cited

Study Snapshot

Anti-acid treatment may be beneficial in patients with idiopathic pulmonary fibrosis, as abnormal acid gastro-oesophageal reflux contributes to disease progression.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

References

Citations